Skip to contentE
Eledon Pharmaceuticals, Inc.
E
ELDNEledon Pharmaceuticals, Inc. Released Mar 18, 2015, after the close
10-K filed Mar 26, 2015, 85 days after period end · 0001193125-15-107051
Q4 2014 · 10-K
Revenue$0.00$0.00— vs Q4 2013no prior Q3 2014 on file Net Income-$6.21M-$6.21M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Eledon Pharmaceuticals, Inc. · CIK 1404281 · Engraved from SEC EDGAR
N/M vs Q3 2014
EPS Diluted-$0.28-$0.28N/M vs Q4 2013N/M vs Q3 2014 Operating Income-$6,261,000N/M Operating Cash Flowderived-$6,460,000N/M Free Cash Flowderived-$6,460,000N/M ended Dec 31, 2014 · filed Mar 26, 2015 · 85 d after period end